Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy

You may also be interested in:

Report/Poster of Convention/Congress Act

Deficits in social cognition and genetic predisposition to schizophrenia: a comparison between patients with 22q11.2 deletion syndrome, schizophrenic patients and healthy controls

Authors: M. Frascarelli, A. Buzzanca, G. Padovani, T. Acinni, L. Carlone, F. Ghezzi, G. Lattanzi, M. Fanella, C. Lambiase, B. marina, M. Biondi, F. di Fabio

Date: 2019

Scope of interest: Rare diseases/psychiatric disorders

Read details

Report/Poster of Convention/Congress Act

22q11.2 deletion and epilepsy: syndromic contexts and neurophysiological aspects

Authors: M. Fanella, A. Morano, J. Fattouch, S. Casciato, M. Albini, L.M. Basili, M. Frascarelli, T. Accinni, A. Buzzanca, A.T. Giallonardo, M. Biondi, F. Di Fabio, C. Di Bonaventura

Date: 2018

Scope of interest: Rare diseases/epilepsy

Read details

Magazine